Antibody-Drug Conjugates: Possibilities and Challenges

The design of Antibody Drug Conjugates (ADCs) as efficient targeting agents for tumor cell is still in its infancy for clinical applications. This approach incorporates the antibody specificity and cell killing activity of chemically conjugated cytotoxic agents. Antibody in ADC structure acts as a t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nejadmoghaddam, Mohammad-Reza, Minai-Tehrani, Arash, Ghahremanzadeh, Ramin, Mahmoudi, Morteza, Dinarvand, Rassoul, Zarnani, Amir-Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Research Institute 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359697/
https://www.ncbi.nlm.nih.gov/pubmed/30800238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359697/
https://www.ncbi.nlm.nih.gov/pubmed/30800238

Ejemplares similares